// App-Quantinova.ai

: Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes

Researchers

Presenter

  • Elisa Lucchini

Principal Investigators

  • Asad Luqmani

  • Maria Atta

  • Simona Deplano

  • Mark Layton

  • Camelia Vladescu

  • Deena Paul

  • Andreas Kousios

  • Rawya Charif

  • Nichola Cooper

Medical Centers

  • Clinica Ematologica, Centro Trapianti e Terapie Cellulari “C. Melzi”,DAME, Università degli Studi,Udine,Italy

  • Imperial College, London, United Kingdom

  • Haematology, Hammesmith Hospital, London, United Kingdom

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • St Marys Hospital, Imperial CollegeHealthcare NHS Trust, London, UK

  • Department of Haematology,Guy's Hospital,London,United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Thrombocytopenia

  • Anemia

  • Autoimmune hemolytic anemia

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved